Skip to main content

Big Pharma challenges suppliers on sustainability

10th August 2023

Submitted by:

Andrew Warmington

Members of the Sustainable Markets Initiative Health Systems Task Force have published an open letter to suppliers in the supply chain, asking them to commit to joining the initiative and working towards climate and sustainability targets. The CEOs of AstraZeneca, GSK, Merck& Co., Novo Nordisk, Sanofi and Samsung Biologics, and the chairman of Roche all signed it.

The letter begins by describing the climate crisis as “one of the most urgent risks to global health”, with over 7 million people/year dying prematurely from air pollution alone. “At the same time, the healthcare sector contributes approximately 5% of global greenhouse gas emissions, with around half of this footprint coming from healthcare supply chains”, and joint action is therefore needed.

“Having launched a set of core commitments at COP27, we are scaling our impact above and beyond the actions we are taking within our own organisations. As part of this, we have set joint, minimum climate and sustainability targets for suppliers which aim to address emissions across the value chain and reduce the complexity of multiple asks.”

These targets, which all suppliers are being urged to commit to at a minimum, were formulated by seeking the best practices from various contributors in the industry. They are to:

* Assess and disclose Scope 1, 2 and 3 emissions by 2025

* Commit to setting near-term targets aligned with the 1.5°C pathway set by the Science-Based Target Initiative (SBTi) by 2025

* Set targets to reduce waste (including solvents) and energy and reuse materials in manufacturing by 2025

* Publicly commit to switch to at least 80% renewable power by 2030 and explore options to source green heat

Transport suppliers should make SBTi-aligned commitments by 2025 and include green transportation solutions in their core offering by 2030. They should also commit to setting standards for own suppliers, set targets to increase water-efficiency and commit to adopting water stewardship standards.

“Shifting to net zero, climate resilient health systems cannot be achieved in siloes. We must collaborate, across the sector and across borders, to secure a healthier tomorrow,” the letter concludes.

Helm, CAC Nantong expand partnership

Helm has reached an agreement with CAC Nantong Chemical to expand their global partnership. Under

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Sterling suite

CDMOs grow in ADCs

Reflecting the ongoing boom in the development antibody-drug conjugates (ADCs), two Western CDMOs announced expansions

Submitted by:

Andrew Warmington

Flamma Lundbeck

Flamma buys Lundbeck site

Italian CDMO Flamma has entered into an agreement to acquire Lundbeck Pharmaceuticals Italy (LuPI) from

Submitted by:

Andrew Warmington

Opening ceremony at UPM's biorefinery in Leuna

UPM opens biorefinery in Germany

UPM has inaugurated a biorefinery in Leuna, Germany, which will make up to 220,000 tonnes/year

Submitted by:

Andrew Warmington

Solenis pulp centre in Brazil

Solenis moves pulp centre

Solenis has relocated its Pulp Centre of Excellence from the US to a new facility

Submitted by:

Andrew Warmington

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Symrise facility in India

Symrise in double Asian expansion

Symrise has announced that it has opened its new Scent Creative Centre in Singapore and

Submitted by:

Andrew Warmington

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

Semiconductor manufacturing

Sumitomo Chemical works with Tata

Sumitomo Chemical has signed a Memorandum of Understanding with India’s Tata Electronics to explore a

Submitted by:

Andrew Warmington

FramoChem and VanDeMark are separated

VanDeMark separation is complete

Japan’s Hodogaya Chemical has completed the previously announced acquisition of Hungarian API and intermediates producer

Submitted by:

Andrew Warmington